Capromab
Capromab is an anti-human PSMA-targeting monoclonal antibody. Capromab binds specifically to the intracellular domain of PSMA, does not undergo internalization after binding, and targets necrotic cells with disrupted membranes. Capromab can be used for the research of prostate cancer.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 151763-64-3
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
Mouse IgG1 kappa
Human
Capromab (Radiolabeled) (10 nM; 2 h) binds specifically to permeabilized PSMA-expressing LNCaP cells, with minimal unspecific binding to PSMA-negative PC3 cell membranes[1].
Capromab (125I-capromab) (10 nM) retains an immunoreactive fraction of 83 ± 2% when binding to PSMA-expressing LNCaP cell membranes[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:BALB/c nu/nu mice (male; subcutaneous PC3 xenograft, 3 weeks post-injection)[1]
-
Dosage:3 μg total antibody per animal
-
Administration:i.v. (tail vein); single dose
-
Result:Showed significantly lower (p < 0.01) tumor uptake in PSMA-negative PC3 xenografts compared to PSMA-positive LNCaP xenografts, with uptake levels comparable to muscle tissue.
FOLH1/PSMA
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
Product Image
ELISA, FACS, Functional assay
化学情報
-
CAS 番号 151763-64-3
-
SMILES
[Capromab]
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)